{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:17:51Z","timestamp":1790983071157,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,21]]},"DOI":"10.7759\/cureus.113113","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:43:06Z","timestamp":1784659386000},"source":"Crossref","is-referenced-by-count":1,"title":["Metastatic Cutaneous Apocrine Carcinoma: Diagnostic and Therapeutic Challenges in a Rare Malignancy"],"prefix":"10.7759","author":[{"given":"Bryan L","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Iguh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.22023","article-title":"Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm","volume":"105","author":"Hollowell KL","year":"2012","unstructured":"Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL. Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol. 2012, 105:415-9. 10.1002\/jso.22023","journal-title":"J Surg Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_341_19","article-title":"Primary cutaneous apocrine carcinoma: case report and literature review","volume":"64","author":"Chadha S","year":"2021","unstructured":"Chadha S, Kumar R, Singhal S, Ruhela S. Primary cutaneous apocrine carcinoma: case report and literature review. Indian J Pathol Microbiol. 2021, 64:183-5. 10.4103\/IJPM.IJPM_341_19","journal-title":"Indian J Pathol Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181590ba4","article-title":"Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases","volume":"32","author":"Robson A","year":"2008","unstructured":"Robson A, Lazar AJ, Ben Nagi J, et al.. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol. 2008, 32:682-90. 10.1097\/PAS.0b013e3181590ba4","journal-title":"Am J Surg Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.09.007","article-title":"Cutaneous and mammary apocrine carcinomas have different immunoprofiles","volume":"45","author":"Piris A","year":"2014","unstructured":"Piris A, Peng Y, Boussahmain C, Essary LR, Gudewicz TM, Hoang MP. Cutaneous and mammary apocrine carcinomas have different immunoprofiles. Hum Pathol. 2014, 45:320-6. 10.1016\/j.humpath.2013.09.007","journal-title":"Hum Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2016.28.5.669","article-title":"Primary cutaneous apocrine carcinoma","volume":"28","author":"Loh SH","year":"2016","unstructured":"Loh SH, Oh YJ, Lew BL, Sim WY. Primary cutaneous apocrine carcinoma. Ann Dermatol. 2016, 28:669-70. 10.5021\/ad.2016.28.5.669","journal-title":"Ann Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105077","article-title":"Current diagnosis and treatment options for cutaneous adnexal neoplasms with apocrine and eccrine differentiation","volume":"22","author":"P\u0142achta I","year":"2021","unstructured":"P\u0142achta I, Kleibert M, Czarnecka AM, Spa\u0142ek M, Szumera-Cie\u0107kiewicz A, Rutkowski P. Current diagnosis and treatment options for cutaneous adnexal neoplasms with apocrine and eccrine differentiation. Int J Mol Sci. 2021, 22:5077. 10.3390\/ijms22105077","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/GO-25-00180","article-title":"Effectiveness and prognosis of systemic chemotherapy for unresectable malignant apocrine and eccrine tumors: a real-world multicenter retrospective study","volume":"11","author":"Saito S","year":"2025","unstructured":"Saito S, Yasuda M, Araki T, et al.. Effectiveness and prognosis of systemic chemotherapy for unresectable malignant apocrine and eccrine tumors: a real-world multicenter retrospective study. JCO Glob Oncol. 2025, 11:e2500180. 10.1200\/GO-25-00180","journal-title":"JCO Glob Oncol"},{"key":"ref8","article-title":"WHO Classification of Skin Tumours. 4th Edition","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. WHO Classification of Skin Tumours. 4th Edition. Elder DE, Massi D, Scolyer RA, Willemze R (ed): International Agency for Research on Cancer, Lyon, France; 2018."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3434","article-title":"Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy - a case report","volume":"8","author":"Collette F","year":"2020","unstructured":"Collette F, Hamoir M, Van Eeckhout P, D'Abadie P, Duprez T, Schmitz S, Machiels JP. Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy - a case report. Clin Case Rep. 2020, 8:3472-8. 10.1002\/ccr3.3434","journal-title":"Clin Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyae103","article-title":"A review of cutaneous apocrine carcinoma: epidemiology, diagnosis, prognosis, and treatment options","volume":"54","author":"Tsuruta S","year":"2024","unstructured":"Tsuruta S, Ogata D, Namikawa K, Nakano E, Yamazaki N. A review of cutaneous apocrine carcinoma: epidemiology, diagnosis, prognosis, and treatment options . Jpn J Clin Oncol. 2024, 54:1135-40. 10.1093\/jjco\/hyae103","journal-title":"Jpn J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.2507","article-title":"Metastatic cutaneous apocrine adenocarcinoma treated with a combination of pertuzumab-based targeted therapy and taxane chemotherapy: a case report","volume":"152","author":"Otsuka M","year":"2016","unstructured":"Otsuka M, Yamasaki O, Kaji T, Shien T, Iwatsuki K. Metastatic cutaneous apocrine adenocarcinoma treated with a combination of pertuzumab-based targeted therapy and taxane chemotherapy: a case report. JAMA Dermatol. 2016, 152:111-3. 10.1001\/jamadermatol.2015.2507","journal-title":"JAMA Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.11.008","article-title":"Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab","volume":"90","author":"Rogatsch M","year":"2018","unstructured":"Rogatsch M, Schmid J, Lax S, Uranitsch M, Schmid-Zalaudek K, Giuffrida R, Zalaudek I. Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab. Eur J Cancer. 2018, 90:146-8. 10.1016\/j.ejca.2017.11.008","journal-title":"Eur J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17777","article-title":"Metastatic cutaneous apocrine adenocarcinoma successfully treated with nivolumab","volume":"52","author":"Murayama Y","year":"2025","unstructured":"Murayama Y, Shojiguchi N, Kawasaki T, et al.. Metastatic cutaneous apocrine adenocarcinoma successfully treated with nivolumab. J Dermatol. 2025, 52:e648-50. 10.1111\/1346-8138.17777","journal-title":"J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510353-metastatic-cutaneous-apocrine-carcinoma-diagnostic-and-therapeutic-challenges-in-a-rare-malignancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:43:07Z","timestamp":1784659387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510353-metastatic-cutaneous-apocrine-carcinoma-diagnostic-and-therapeutic-challenges-in-a-rare-malignancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.113113","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}